相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, That Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy
Po C. Chen et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy
Melissa Bowerman et al.
BMC MEDICINE (2012)
Valproic acid increases SMN2 expression and modulates SF2/ASF and hnRNPA1 expression in SMA fibroblast cell lines
Indra Sari Kusuma Harahap et al.
BRAIN & DEVELOPMENT (2012)
A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse
Paul N. Porensky et al.
HUMAN MOLECULAR GENETICS (2012)
Identification of Novel Compounds That Increase SMN Protein Levels Using an Improved SMN2 Reporter Cell Assay
Jonathan J. Cherry et al.
JOURNAL OF BIOMOLECULAR SCREENING (2012)
Differential regulation of the SMN2 gene by individual HDAC proteins
Matthew C. Evans et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid
Illora A. Darbar et al.
BMC NEUROLOGY (2011)
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms
Monica Nizzardo et al.
EXPERIMENTAL NEUROLOGY (2011)
Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice
Elisa Dominguez et al.
HUMAN MOLECULAR GENETICS (2011)
The COPI vesicle complex binds and moves with survival motor neuron within axons
Cyril Jayakumar Peter et al.
HUMAN MOLECULAR GENETICS (2011)
Increasing expression and decreasing degradation of SMN ameliorate the spinal muscular atrophy phenotype in mice
Deborah Y. Kwon et al.
HUMAN MOLECULAR GENETICS (2011)
Synthesis and Characterization of Pseudocantharidins, Novel Phosphatase Modulators That Promote the Inclusion of Exon 7 into the SMN (Survival of Motoneuron) pre-mRNA
Zhaiyi Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway
Faraz Farooq et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Discovery, Synthesis, and Biological Evaluation of Novel SMN Protein Modulators
Jingbo Xiao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
Yimin Hua et al.
NATURE (2011)
A screen for regulators of survival of motor neuron protein levels
Nina R. Makhortova et al.
NATURE CHEMICAL BIOLOGY (2011)
Hydroxyurea enhances SMN2 gene expression through nitric oxide release
Cheng Xu et al.
NEUROGENETICS (2011)
Utility of Survival Motor Neuron ELISA for Spinal Muscular Atrophy Clinical and Preclinical Analyses
Dione T. Kobayashi et al.
PLOS ONE (2011)
SMA CARNI-VAL TRIAL PART II: A Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy
John T. Kissel et al.
PLOS ONE (2011)
Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
Marco A. Passini et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
SMN in spinal muscular atrophy and snRNP biogenesis
Tristan H. Coady et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2011)
Molecular and phenotypic reassessment of an infrequently used mouse model for spinal muscular atrophy
Rocky G. Gogliotti et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Embryonic stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice
Stefania Corti et al.
BRAIN (2010)
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Yimin Hua et al.
GENES & DEVELOPMENT (2010)
Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy
Matthew E. R. Butchbach et al.
HUMAN MOLECULAR GENETICS (2010)
SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy
Markus Riessland et al.
HUMAN MOLECULAR GENETICS (2010)
Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model
Melissa Bowerman et al.
HUMAN MOLECULAR GENETICS (2010)
CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy
Marco A. Passini et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design
Francesco Danilo Tiziano et al.
JOURNAL OF MEDICAL GENETICS (2010)
Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2010)
Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy
Magali Michaud et al.
NEUROBIOLOGY OF DISEASE (2010)
Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy
T. -H. Chen et al.
NEUROLOGY (2010)
Histological and Functional Benefit Following Transplantation of Motor Neuron Progenitors to the Injured Rat Spinal Cord
Sharyn L. Rossi et al.
PLOS ONE (2010)
SMA CARNI-VAL Trial Part I: Double-Blind, Randomized, Placebo-Controlled Trial of L-Carnitine and Valproic Acid in Spinal Muscular Atrophy
Kathryn J. Swoboda et al.
PLOS ONE (2010)
Systemic Delivery of scAAV9 Expressing SMN Prolongs Survival in a Model of Spinal Muscular Atrophy
Chiara F. Valori et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Subcutaneous administration of TC007 reduces disease severity in an animal model of SMA
Virginia B. Mattis et al.
BMC NEUROSCIENCE (2009)
Regulation of protein stability by GSK3 mediated phosphorylation
Chong Xu et al.
CELL CYCLE (2009)
Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model
Virginia B. Mattis et al.
HUMAN MOLECULAR GENETICS (2009)
Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo
Christopher R. Heier et al.
HUMAN MOLECULAR GENETICS (2009)
LBH589 induces up to 10-fold SMN protein levels by several independent mechanisms and is effective even in cells from SMA patients non-responsive to valproate
Lutz Garbes et al.
HUMAN MOLECULAR GENETICS (2009)
p38 Mitogen-activated protein kinase stabilizes SMN mRNA through RNA binding protein HuR
Faraz Farooq et al.
HUMAN MOLECULAR GENETICS (2009)
Induction of Nrf2 and xCT are involved in the action of the neuroprotective antibiotic ceftriaxone in vitro
Jan Lewerenz et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Regulation of SMN Protein Stability
Barrington G. Burnett et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Valproic acid blocks excitability in SMA type I mouse motor neurons
Kristen Rak et al.
NEUROBIOLOGY OF DISEASE (2009)
Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy
Kathryn J. Swoboda et al.
PLOS ONE (2009)
Tetracyclines That Promote SMN2 Exon 7 Splicing as Therapeutics for Spinal Muscular Atrophy
Michelle L. Hastings et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Donor-Derived Brain Tumor Following Neural Stem Cell Transplantation in an Ataxia Telangiectasia Patient
Ninette Amariglio et al.
PLOS MEDICINE (2009)
DcpS as a Therapeutic Target for Spinal Muscular Atrophy
Jasbir Singh et al.
ACS CHEMICAL BIOLOGY (2008)
Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in Transgenic mice
Yimin Hua et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Sustained Improvement of Spinal Muscular Atrophy Mice Treated with Trichostatin A Plus Nutrition
Heather L. Narver et al.
ANNALS OF NEUROLOGY (2008)
Riluzole in psychiatry: a systematic review of the literature
Carlos A. Zarate et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2008)
Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis
C. Habold et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy
Stefania Corti et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Deacetylase activity is required for STAT5-dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells
Carlos Sebastian et al.
JOURNAL OF IMMUNOLOGY (2008)
Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy
John Thurmond et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice
Li-Kai Tsai et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2008)
Specific Antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy
Thierry Bordet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The effect of hydroxyurea in spinal muscular atrophy cells and patients
Wen-Chen Liang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Daily salbutamol in young patients with SMA type II
Marika Pane et al.
NEUROMUSCULAR DISORDERS (2008)
Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells
C. Angelozzi et al.
JOURNAL OF MEDICAL GENETICS (2008)
Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis
Thierry Bordet et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Spinal muscular atrophy: Clinical classification and disease heterogeneity
Barry S. Russman
JOURNAL OF CHILD NEUROLOGY (2007)
Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy
Amy M. Avila et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Stat5 constitutive activation rescues defects in spinal muscular atrophy
Chen-Hung Ting et al.
HUMAN MOLECULAR GENETICS (2007)
Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord
Jun Yan et al.
PLOS MEDICINE (2007)
Smn depletion alters profilin II expression and leads to upregulation of the RhoA/ROCK pathway and defects in neuronal integrity
Melissa Bowerman et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2007)
Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes
Natalia N. Singh et al.
NUCLEIC ACIDS RESEARCH (2007)
Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts
Virginia B. Mattis et al.
HUMAN GENETICS (2006)
The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells
Markus Riessland et al.
HUMAN GENETICS (2006)
Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical libraries
James Inglese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy
E Hahnen et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron
NK Singh et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2
L Cartegni et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells
SM Grzeschik et al.
ANNALS OF NEUROLOGY (2005)
The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation
F Gabanella et al.
HUMAN MOLECULAR GENETICS (2005)
Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice
BJ Cummings et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy
J Jarecki et al.
HUMAN MOLECULAR GENETICS (2005)
Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury
HS Keirstead et al.
JOURNAL OF NEUROSCIENCE (2005)
A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels
EC Wolstencroft et al.
HUMAN MOLECULAR GENETICS (2005)
SMNΔ7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN
TT Le et al.
HUMAN MOLECULAR GENETICS (2005)
Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation
GI Nistor et al.
GLIA (2005)
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
JD Rothstein et al.
NATURE (2005)
The role of the Rho GTPases in neuronal development
EE Govek et al.
GENES & DEVELOPMENT (2005)
Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment
L Bidou et al.
GENE THERAPY (2004)
An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy
NN Singh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Pilot trial of phenylbutyrate in spinal muscular atrophy
E Mercuri et al.
NEUROMUSCULAR DISORDERS (2004)
Modulation of SMN nuclear foci and cytoplasmic localization by its C-terminus
Y Hua et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
Survival motor neuron SMN1 and SMN2 gene promoters: identical sequences and differential expression in neurons and non-neuronal cells
B Boda et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2004)
In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes
NN Singh et al.
RNA (2004)
Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism
MR Lunn et al.
CHEMISTRY & BIOLOGY (2004)
Homozygous SMN1 deletions in unaffected family members and modification of the phenotype by SMN2
TW Prior et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2004)
Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy
C Andreassi et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2004)
Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons
W Rossoll et al.
JOURNAL OF CELL BIOLOGY (2003)
Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations
M Wilschanski et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy
L Brichta et al.
HUMAN MOLECULAR GENETICS (2003)
Riluzole attenuates spinal muscular atrophy disease progression in a mouse model
H Haddad et al.
MUSCLE & NERVE (2003)
Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding
ML McWhorter et al.
JOURNAL OF CELL BIOLOGY (2003)
A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy
T Kashima et al.
NATURE GENETICS (2003)
Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5
A Rascle et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy
UR Monani et al.
JOURNAL OF CELL BIOLOGY (2003)
A phase 1 trial of Riluzole in spinal muscular atrophy
BS Russman et al.
ARCHIVES OF NEUROLOGY (2003)
Valproic acid increases SMN levels in spinal muscular atrophy patient cells
CJ Sumner et al.
ANNALS OF NEUROLOGY (2003)
Essential role for the SMN complex in the specificity of snRNP assembly
L Pellizzoni et al.
SCIENCE (2002)
Pilot trial of albuterol in spinal muscular atrophy
M Kinali et al.
NEUROLOGY (2002)
Survival motor neuron (SMN) protein: role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development
L Fan et al.
HUMAN MOLECULAR GENETICS (2002)
Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1
L Cartegni et al.
NATURE GENETICS (2002)
Quantitative analyses of SMN1 and SMN2 based on real-time LightCycler PCR:: Fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy
M Feldkötter et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription
H Nakajima et al.
EMBO JOURNAL (2001)
Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients
C Andreassi et al.
HUMAN MOLECULAR GENETICS (2001)
Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy
JT Kissel et al.
NEUROLOGY (2001)
An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA
ML Zhang et al.
GENE THERAPY (2001)
Treatment of spinal muscular atrophy by sodium butyrate
JG Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Co-regulation of survival of motor neuron (SMN) protein and its interactor SIP1 during development and in spinal muscular atrophy
S Jablonka et al.
HUMAN MOLECULAR GENETICS (2001)
Characterization of a nuclear 20S complex containing the survival of motor neurons (SMN) protein and a specific subset of spliceosomal Sm proteins
G Meister et al.
HUMAN MOLECULAR GENETICS (2000)
The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn-/- mice and results in a mouse with spinal muscular atrophy
UR Monani et al.
HUMAN MOLECULAR GENETICS (2000)
An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN
CL Lorson et al.
HUMAN MOLECULAR GENETICS (2000)
The role of SMN in spinal muscular atrophy
S Jablonka et al.
JOURNAL OF NEUROLOGY (2000)
A mouse model for spinal muscular atrophy
HM Hsieh-Li et al.
NATURE GENETICS (2000)
分享论文
